- Oops!Something went wrong.Please try again later.
NEW YORK, NY / ACCESSWIRE / July 31, 2018 / U.S. markets continued to drop on Monday, as tech sector close in the red weighed by majority of the FAANG (Facebook, Apple, Amazon, Netflix and Google parent Alphabet) stocks. The Dow Jones Industrial Average fell 0.57 percent to close at 25,306.83, while the S&P 500 Index was down 0.58 percent to close at 2,802.60. The Nasdaq Composite Index declined 1.39 percent to close at 7,630.00.
"The market is punishing companies that don't beat on revenue or earnings, or which give a bad outlook. You need to win on all three to do well, and if you miss, like Facebook did, you get pummeled," said director of global market research at Boston Partners, Michael Mullaney.
RDI Initiates Coverage on:
Bristol-Myers Squibb Company
Bristol-Myers Squibb's stock jumped 3.53% Monday, to close the day at $58.93. The stock recorded a trading volume of 8,096,923 shares, which was above its three months average volume of 7,129,855 shares. In the last year, Bristol-Myers Squibb's shares have traded in a range of 49.96 - 70.05. The share price has gained 17.95% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $55.59 is below its 200-day moving average of $58.58. Shares of the company are trading at a Price to Earnings ratio of 105.04. Shares of Bristol-Myers Squibb have gained roughly 6.49 percent in the past month and are down 3.83 percent year-to-date.
Access RDI's Bristol-Myers Squibb Company Research Report at:
On Monday, shares of Allergan recorded a trading volume of 2,982,683 shares, which was above the three months average volume of 2,360,412 shares. The stock ended the day 3.01% higher at $183.99. The share price has fallen 27.99% from its 52 week high with a 52 week trading range of 142.81 - 255.52. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $173.07 is above its 200-day moving average of $165.10. Shares of Allergan have gained roughly 10.36 percent in the past month and are up 12.48 percent year-to-date.
Access RDI's Allergan plc Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.